Cargando…
Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures
AIM: The use of recombinant human platelet-derived growth factor–BB (rhPDGF) has received Food and Drug Administration approval for the treatment of periodontal and orthopedic bone defects and dermal wound healing. Many studies have investigated its regenerative potential in a variety of other oral...
Autores principales: | Tavelli, L., Ravidà, A., Barootchi, S., Chambrone, L., Giannobile, W.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961612/ https://www.ncbi.nlm.nih.gov/pubmed/32392438 http://dx.doi.org/10.1177/2380084420921353 |
Ejemplares similares
-
Recombinant human platelet‐derived growth factor improves root coverage of a collagen matrix for multiple adjacent gingival recessions: A triple‐blinded, randomized, placebo‐controlled trial
por: Tavelli, Lorenzo, et al.
Publicado: (2022) -
Research for Prevention of Oral/Dental Diseases: How Far Have We Come?
por: Schwendicke, F., et al.
Publicado: (2019) -
Soft tissue phenotype modification predicts gingival margin long‐term (10‐year) stability: Longitudinal analysis of six randomized clinical trials
por: Barootchi, Shayan, et al.
Publicado: (2022) -
Regenerative Medicine Technologies to Treat Dental, Oral, and Craniofacial Defects
por: Latimer, Jessica M., et al.
Publicado: (2021) -
Platelet-Derived Extracellular Vesicles for Regenerative Medicine
por: Antich-Rosselló, Miquel, et al.
Publicado: (2021)